PEPG - יחס חוב להיוון בספרים pepgen.com

High R&D expenses are keeping the operating leverage of PepGen Inc. (PEPG) in the negative, which is confirmed by the debt-to-equity ratio on this GURU.Markets platform chart, where the 0.13 level represents the current value. The business relies on non-cyclical demand in neuromedicine, yet faces a fierce struggle for drug delivery efficiency into cells.

For PepGen Inc. (PEPG), which implements robotic bioscreening into drug development, this indicator determines capital dependence on borrowed funds. The metric compares total liabilities with the actual value of net assets, revealing the balance between financial leverage and equity. By analyzing the financing structure—debt to book capitalization—an investor assesses the cost of debt service. An increase in this ratio may reflect investments in synthesizer automation. The stability of this coefficient confirms the sustainability of the company's technological development.